JESSICA WOO: Open Payments
NPI 1821611724 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 36 payments from 12 companies in 2025. Trend: 2023 $312 · 2024 $635 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 6 | $147 |
| GlaxoSmithKline, LLC. | 7 | $140 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $107 |
| ABBVIE INC. | 5 | $100 |
| Aimmune Therapeutics, Inc. | 2 | $85 |
| Lilly USA, LLC | 3 | $81 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Exact Sciences Corporation | 2 | $44 |
| Merck Sharp & Dohme LLC | 1 | $23 |
Products named: ZORYVE, AIRSUPRA, AREXVY, ZENPEP, MOUNJARO, LINZESS, VOQUEZNA, OFEV.
Industry payments across CA — which companies pay providers there.
